IFNG and systemic lupus erythematosus: Thus, the IFN-γ release, which is measured by the widely used TB-IGRA measurement in clinics, may be a useful biomarker for pediatric SLE patients to distinguish from other rheumatoid disease such as JDM and JIA (Fig. 2), where is consistent with a report on adult SLE [12].